Literature DB >> 7219252

Tropical pyomyositis, a thiamine-deficiency disease.

D Engel.   

Abstract

On the basis of clinical observations made in Shanghai which confirmed the clinical and experimental findings of Osawa in Japan, it is suggested that thiamine deficiency is an essential contributary factor in producing tropical pyomyositis (TPM). It was found that the majority of patients affected by TPM suffer or have previously suffered from beriberi. The practical disappearance of TPM in Japan in recent years supports the above view. Thiamine deficiency induces a biochemical lesion (Peters) in the pyruvate oxidase system of the muscle, which breaks down its normal resistance to infection and opens the gate to bacterial agents. It is possible that in different parts of the world other or additional factors may play a similar role to that of thiamine deficiency. It is suggested that a wide survey should be undertaken--perhaps by the World Health Organisation--especially in areas in which TPM is endemic, using all relevant methods, to elucidate the factor or factors responsible for the development of TPM.

Entities:  

Mesh:

Year:  1981        PMID: 7219252     DOI: 10.1016/0306-9877(81)90071-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  Pyomyositis mimicking right iliac fossa mass: review of the literature.

Authors:  O C Iwuagwu; G T Deans
Journal:  Ann R Coll Surg Engl       Date:  2000-09       Impact factor: 1.891

2.  Tropical pyomyositis.

Authors:  L Ansaloni
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

Review 3.  Nontropical pyomyositis in patients with AIDS.

Authors:  S J Antony; D S Kernodle
Journal:  J Natl Med Assoc       Date:  1996-09       Impact factor: 1.798

Review 4.  Enterobacter cloacae pyomyositis complicating chronic granulomatous disease and review of gram-negative bacilli pyomyositis.

Authors:  M Gousseff; F Lanternier; A Ferroni; O Chandesris; N Mahlaoui; O Hermine; O Lortholary; M Lecuit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-01       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.